This Drug Talks to Three Fat Loss Switches at Once (Ozempic Only Hits One). 26% of What You Lose Isn't Fat

Retatrutide has become the most talked-about weight loss drug that isn’t even approved yet. Clinical trials show results that make Ozempic look like yesterday’s technology, with participants losing nearly 30% of their body weight on average. But filmmaker and fitness enthusiast behind a recent viral deep-dive has spent four weeks using this experimental peptide himself, translating complex medical research into actionable insights most people never hear. What he discovered goes far beyond simple fat loss—and the hidden costs almost made him quit entirely.

This Drug Talks to Three Fat Loss Switches at Once (Ozempic Only Hits One). 26% of What You Lose Isn't Fat. Retatrutide has become the most talked-about weight loss drug that isn’t even approved yet. Clinical trials show results that make Ozempic look like yesterday’s technology, with participants losing nearly 30% of their body weight on average. But filmmaker and fitness enthusiast behind a recent viral deep-dive has spent four weeks using this experimental peptide himself, translating complex medical research into actionable insights most people never hear. What he discovered goes far beyond simple fat loss—and the hidden costs almost made him quit entirely. Jump to: Three Switches That Change Everything Where Other Drugs Stop, Retatrutide Keeps Going Clinical Trial Results That Shocked Researchers The Hidden Story Behind Fat Loss Reve...